Health and Wellness

3 Ways They Fight Loneliness, Boost Safety, And Scale Support

The world is experiencing a significant shift in demographics, with the elderly population growing rapidly. By 2050, over 2.1 billion people will be over the age of 60, highlighting the

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

RFK Jr.’s chronic disease agency budget documents released

Budget documents released by the Trump administration on Friday shed light on the priorities of a proposed new agency aimed

Doctors And Patients Hurt By ‘Big Beautiful Bill’

The American Medical Association has raised concerns about legislation making its way through Congress, warning that it could have detrimental

Promising treatment or potential health risk?

Fecal microbiota transplants (FMT) have long been considered a potential treatment for a range of conditions, including inflammatory bowel diseases,

Food-oriented LLM tackles data challenges to advance nutritional applications

The Institute of Computing Technology of the Chinese Academy of Sciences, in collaboration with other researchers, has introduced a groundbreaking

FDA hints relaxed rules are coming for rare disease gene therapy

The Trump administration's impact on gene therapy was a topic of discussion at a recent FDA "Cell and Gene Therapy

Disadvantaged backgrounds can leave a lifelong accelerated aging marker in children

Economic disadvantage can have a lasting impact on children, affecting their quality and length of life, according to a new

Mailed self-collection HPV tests more than double cervical cancer screening rates, study shows

The University of Texas MD Anderson Cancer Center conducted a groundbreaking study that showed how mail-in self-collection tests for human

This AI Model Could Make It Faster To Find New Medicines

A new AI model called Boltz-2 has been developed by a team from MIT and pharmaceutical company Recursion, with support